Health care workers are changing how they counsel patients. Experts are using our database to support their research. And ...

Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...

GSK gets an entry in the list with Exdensur (depemokimab), a twice-yearly injectable IL-5 inhibitor for severe asthma, which ...

Introduction With the increasing prevalence of asthma in children, exercise has become an essential component of asthma management, playing a significant role in improving overall health and quality ...

Asthma causes inflammation and narrowing of the airways, making it harder to breathe. Symptoms may include wheezing, coughing, chest tightness, and shortness of breath. These symptoms can vary in ...

7 asthma medications: A guide to learn more Asthma is a chronic respiratory condition that affects millions of people of all ages. While there is no cure, modern asthma medications make it possible ...

What Is Exdensur, and Why Does It Matter? Exdensur (depemokimab) is a new type of ultra long-acting biologic medicine approved by the FDA as an add-on maintenance treatment for severe eosinophilic ...

An experimental oral drug claims to do the work of medications like GLP-1s without losing muscle mass. The medication just went through phase 1 clinical trials. Doctors explain the new medication and ...